ARLIN Haute-Normandie, CCLIN Paris Nord, Rouen University Hospital, 1, rue de Germont, 76031 Rouen cedex, France.
ARLIN Haute-Normandie, CCLIN Paris Nord, Rouen University Hospital, 1, rue de Germont, 76031 Rouen cedex, France.
Med Mal Infect. 2017 Sep;47(5):324-332. doi: 10.1016/j.medmal.2017.03.003. Epub 2017 May 24.
French national guidelines state that antibiotic therapies should be reassessed between 48 and 72hours after treatment initiation and that reassessment of antibiotic therapy (RA) must be recorded in patients' files.
To determine whether RA is performed and recorded in patients' files in hospitals in a region of France.
Setting: hospitals participating in the National nosocomial infection point- prevalence survey (NPS) in Upper-Normandy, France. Patients included those receiving antibiotic therapy (excluding antibiotic prophylaxis) on NPS day, started in the hospital in which the survey was conducted and ongoing for more than 72hours. Data collected included characteristics of participating hospitals and, for each included patient, characteristics of ward, infection and antibiotic therapy, and mention in the patients' files of explicit or implicit RA. The rate of explicit and implicit RA was calculated and factors associated with explicit or implicit RA were evaluated using a univariate analysis.
Thirty-three hospitals representing 87% of hospital beds region-wide were included in the study. In addition, 933 prescriptions were assessed for 724 infections in 676 patients. The overall rate of RA was 67.6% (49.3% of explicit RA and 18.3% of implicit RA). The rate of RA differed significantly according to infection and antibiotic class but not according to hospital or ward characteristics.
Our study provides new and reassuring results regarding reassessment of antibiotic therapy.
法国国家指南指出,抗生素治疗应在治疗开始后 48 至 72 小时内重新评估,并且必须在患者的病历中记录抗生素治疗的重新评估(RA)。
确定在法国一个地区的医院中是否对患者的病历进行了 RA 并进行了记录。
地点:参与法国上诺曼底地区全国医院感染现患率调查(NPS)的医院。纳入的患者为在 NPS 日接受抗生素治疗(不包括抗生素预防),在进行调查的医院开始治疗且持续超过 72 小时的患者。收集的数据包括参与医院的特征,以及每位纳入患者的病房、感染和抗生素治疗特征,以及在患者病历中是否明确或隐含 RA 的记录。计算了明确和隐含 RA 的发生率,并使用单因素分析评估了与明确或隐含 RA 相关的因素。
研究纳入了代表该地区 87%床位的 33 家医院。此外,评估了 933 份处方,涉及 676 名患者的 724 例感染。RA 的总体发生率为 67.6%(明确 RA 为 49.3%,隐含 RA 为 18.3%)。RA 的发生率根据感染和抗生素类别而有显著差异,但与医院或病房特征无关。
我们的研究提供了有关抗生素治疗重新评估的新的令人安心的结果。